Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 32176 - 32200 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	TUBB	203068	upregulated	Cisplatin results in increased expression of TUBB mRNA	6p21.33	A22204
Cisplatin	Approved Investigational	TUSC2	11334	upregulated	Cisplatin results in increased expression of TUSC2 mRNA	3p21.31	A22203
Cisplatin	Approved Investigational	TWIST1	7291	upregulated	Cisplatin results in increased expression of TWIST1 mRNA	7p21.1	A22239
Cisplatin	Approved Investigational	TWIST2	117581	downregulated	Cisplatin results in decreased expression of TWIST2 mRNA	2q37.3	A22204
Cisplatin	Approved Investigational	TXN	7295	upregulated	Cisplatin results in increased expression of TXN mRNA	9q31.3	A22205 A20427
Cisplatin	Approved Investigational	TXNRD1	7296	upregulated	Cisplatin results in increased expression of TXNRD1 mRNA	12q23.3	A22205 A20427
Cisplatin	Approved Investigational	TYMP	1890	downregulated	Cisplatin results in decreased expression of TYMP mRNA	22q13.33	A21500
Cisplatin	Approved Investigational	TYMS	7298	upregulated	Cisplatin results in increased expression of TYMS mRNA	18p11.32	A21500 A22269
Cisplatin	Approved Investigational	TYW1	55253	downregulated	Cisplatin results in decreased expression of TYW1 mRNA	7q11.21	A22204
Cisplatin	Approved Investigational	UACA	55075	downregulated	Cisplatin results in decreased expression of UACA mRNA	15q23	A22204
Cisplatin	Approved Investigational	UAP1	6675	upregulated	Cisplatin results in increased expression of UAP1 mRNA	1q23.3	A22204
Cisplatin	Approved Investigational	UBE2E2	7325	downregulated	Cisplatin results in decreased expression of UBE2E2 mRNA	3p24.3	A22204 A22203
Cisplatin	Approved Investigational	UBE2G2	7327	upregulated	Cisplatin results in increased expression of UBE2G2 mRNA	21q22.3	A20427
Cisplatin	Approved Investigational	UBIAD1	29914	upregulated	Cisplatin results in increased expression of UBIAD1 mRNA	1p36.22	A22204
Cisplatin	Approved Investigational	UGDH	7358	upregulated	Cisplatin results in increased expression of UGDH mRNA	4p14	A22204
Cisplatin	Approved Investigational	ULBP2	80328	upregulated	Cisplatin results in increased expression of ULBP2 mRNA	6q25.1	A22204
Cisplatin	Approved Investigational	UMPS	7372	downregulated	Cisplatin results in decreased expression of UMPS mRNA	3q21.2	A21500
Cisplatin	Approved Investigational	USP32	84669	downregulated	Cisplatin results in decreased expression of USP32 mRNA	17q23.3	A22204
Cisplatin	Approved Investigational	USP36	57602	upregulated	Cisplatin results in increased expression of USP36 mRNA	17q25.3	A20660
Cisplatin	Approved Investigational	UTP3	57050	downregulated	Cisplatin results in decreased expression of UTP3 mRNA	4q13.3	A21499
Cisplatin	Approved Investigational	VARS	7407	upregulated	Cisplatin results in increased expression of VARS mRNA	6p21.33	A20427
Cisplatin	Approved Investigational	VASN	114990	upregulated	Cisplatin results in increased expression of VASN mRNA	16p13.3	A22204
Cisplatin	Approved Investigational	VEGFA	7422	downregulated	Cisplatin results in decreased expression of VEGFA mRNA	6p21.1	A22270
Cisplatin	Approved Investigational	VEGFA	7422	upregulated	Cisplatin results in increased expression of VEGFA mRNA	6p21.1	A22271
Cisplatin	Approved Investigational	VIM	7431	upregulated	Cisplatin results in increased expression of VIM mRNA	10p13	A22239

Displaying entries 32176 - 32200 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability